Date and time
Start: Tuesday 8 March 2022, 12:30 PM
End: Tuesday 8 March 2022, 01:30 PM
Tuesday 8 March
Start: Tuesday 8 March 2022, 12:30 PM
End: Tuesday 8 March 2022, 01:30 PM
China and Hong Kong has many changes in the last few years on patent practices. For China, the 4th revision of the Chinese Patent Law has passed, introducing patent term adjustment, drug patent term extension, drug patent linkage, partial design, many changes in patent infringement damage determination, and so on. For Hong Kong, the original grant system was introduced. This webinar will cover these and discuss the impact on the best practice.
All
Born and educated in Hong Kong with a PhD in chemistry and The only Chinese patent attorney working in a Beijing Chinese patent firm from Hong Kong.
Past co-chair of the AIPLA’s IP Practice in China committee and current co-chair of the AIPLA’s IP Practice in the Far East committee and is also Vice Chair of the Asian Practice committee of the IPO.
Trained under the UK system and took the UK CIPA examinations, and passed some of the papers. Responsible for publishing articles on China IP update for the UK CIPA Journal.
Member of AIPLA, IPO, UK CIPA and speaks several languages: Chinese (Mandarin and Cantonese), English
Sign in to your account to register for the event
If you are not yet registered or a member of CIPA, please register here